Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Retained Earnings (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Retained Earnings for 16 consecutive years, with -$16.2 million as the latest value for Q1 2026.

  • Quarterly Retained Earnings rose 28.64% to -$16.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$16.2 million through Jan 2026, up 28.64% year-over-year, with the annual reading at -$16.2 million for FY2026, 28.64% up from the prior year.
  • Retained Earnings for Q1 2026 was -$16.2 million at Usana Health Sciences, up from -$19.3 million in the prior quarter.
  • The five-year high for Retained Earnings was $474.5 million in Q3 2024, with the low at -$22.8 million in Q1 2025.
  • Average Retained Earnings over 5 years is $104.2 million, with a median of -$16.2 million recorded in 2026.
  • Peak annual rise in Retained Earnings hit 9607.23% in 2022, while the deepest fall reached 889.12% in 2022.
  • Over 5 years, Retained Earnings stood at $391.6 million in 2022, then plummeted by 103.5% to -$13.7 million in 2023, then crashed by 65.53% to -$22.7 million in 2024, then rose by 14.91% to -$19.3 million in 2025, then rose by 16.13% to -$16.2 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$16.2 million, -$19.3 million, and -$19.3 million for Q1 2026, Q3 2025, and Q2 2025 respectively.